Universal H1N1 influenza vaccine development: Identification of consensus class II hemagglutinin and neuraminidase epitopes derived from strains circulating between 1980 and 2011

by Adam | Oct 22, 2016

Human Vaccines & Immunotherapeutics 2013; 9:1598 – 1607; PMID: 23846304; https://dx.doi.org/10.4161/hv.25598

The two-faced T cell epitope: Examining the host-microbe interface with JanusMatrix

by Adam | Oct 22, 2016

Hum Vaccin Immunother. 2013 Apr 12;9(7). PubMed PMID 23584251

Report from the field: Overview of the Sixth Annual Vaccine Renaissance Conference

by Adam | Oct 22, 2016

Hum Vaccin Immunother. 2013 Jul;9(7):1555-7. doi: 10.4161/hv.24833. Epub 2013 May 31.

Low immunogenicity predicted for emerging avian-origin H7N9: Implication for influenza vaccine design

by Adam | Oct 22, 2016

Hum Vaccin Immunother. Volume 9, Issue 5 May 2013:950–956.

Making Vaccines “On Demand”: A Potential Solution for Emerging Pathogens and Biodefense?

by Adam | Oct 22, 2016

Human Vaccines and Immunotherapy. Sep 2013.